| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
7,074 |
6,102 |
$572K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,358 |
6,306 |
$488K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,592 |
5,858 |
$309K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,508 |
5,101 |
$263K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
9,747 |
7,029 |
$120K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,705 |
2,595 |
$27K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,593 |
1,096 |
$27K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
756 |
480 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,106 |
898 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,311 |
2,020 |
$11K |
| 99205 |
Prolong outpt/office vis |
57 |
54 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
759 |
528 |
$4K |
| 99215 |
Prolong outpt/office vis |
25 |
22 |
$2K |
| 81002 |
|
877 |
732 |
$682.18 |
| 76140 |
|
34 |
30 |
$480.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
203 |
178 |
$154.12 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$82.77 |
| 81025 |
|
30 |
25 |
$60.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
89 |
58 |
$29.06 |
| 99000 |
|
397 |
365 |
$0.00 |
| 99051 |
|
6,805 |
5,799 |
$0.00 |